Advertisement
Available through the Zeus worldwide distribution network, the new MRSAtest will enable healthcare professionals to identify carriers of thispathogen within two hours. Published studies have shown that time-to-resultsis critical in demonstrating a reduction in MRSA hospital infection rates.
Advertisement
In addition to significantly improving assay performance over othertechnologies in this product space, the nasal MRSA test will be offered as alow cost alternative to the two currently FDA approved MRSA PCR productswithout sacrificing time to results or performance.
Zeus is uniquely positioned in this area through relevant patent filings,further expanding its Intellectual Property portfolio and providing newproduct protection.
About Zeus Scientific, Inc.
Zeus Scientific, Inc. is a global leader in the field of clinicaldiagnostics products. Zeus has a developing pipeline of innovative, highquality, and cost-effective diagnostic solutions geared toward the enhancementof patient care. Zeus' products are marketed and distributed worldwide througha vast network of quality distribution partnerships.
For additional information about the nasal screening test for MRSA, pleasecontact Zeus at 908-526-3744 or visit our web site at www.zeusscientific.com.Contact: James S. Vingara Zeus Scientific, Inc. 908-526-3744 [email protected]
SOURCE Zeus Scientific, Inc.
